The global burden of coeliac disease: opportunities and challenges

GK Makharia, P Singh, C Catassi, DS Sanders… - Nature Reviews …, 2022 - nature.com
Coeliac disease is a systemic disorder characterized by immune-mediated enteropathy,
which is caused by gluten ingestion in genetically susceptible individuals. The clinical …

AGA clinical practice update on diagnosis and monitoring of celiac disease—changing utility of serology and histologic measures: expert review

S Husby, JA Murray, DA Katzka - Gastroenterology, 2019 - Elsevier
Purpose The purpose of this clinical practice update is to define key modalities in the
diagnosis and monitoring of celiac disease (CD) in adults as well as in children and …

American College of Gastroenterology guidelines update: diagnosis and management of celiac disease

A Rubio-Tapia, ID Hill, C Semrad… - Official journal of the …, 2023 - journals.lww.com
This guideline presents an update to the 2013 American College of Gastroenterology
Guideline on the Diagnosis and Management of Celiac Disease with updated …

Coeliac disease

B Lebwohl, DS Sanders, PHR Green - The Lancet, 2018 - thelancet.com
Coeliac disease occurs in about 1% of people in most populations. Diagnosis rates are
increasing, and this seems to be due to a true rise in incidence rather than increased …

Coeliac disease

C Catassi, EF Verdu, JC Bai, E Lionetti - The Lancet, 2022 - thelancet.com
Coeliac disease is an autoimmune disorder that primarily affects the small intestine, and is
caused by the ingestion of gluten in genetically susceptible individuals. Prevalence in the …

AGA clinical practice update on management of refractory celiac disease: expert review

PHR Green, S Paski, CW Ko, A Rubio-Tapia - Gastroenterology, 2022 - Elsevier
Description The purpose of this expert review is to summarize the diagnosis and
management of refractory celiac disease. It will review evaluation of patients with celiac …

Refractory celiac disease

IA Hujoel, JA Murray - Current gastroenterology reports, 2020 - Springer
Abstract Purpose of Review To review the epidemiology, pathophysiology, diagnosis,
management, and prognosis of refractory celiac disease, with a specific emphasis on recent …

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

C Cellier, G Bouma, T Van Gils, S Khater… - The Lancet …, 2019 - thelancet.com
Background Refractory coeliac disease type 2 is a rare subtype of coeliac disease with high
mortality rates; interleukin 15 (IL-15) is strongly implicated in its pathophysiology. This trial …

Diagnosis and treatment patterns in celiac disease

AB Cichewicz, ES Mearns, A Taylor… - Digestive diseases and …, 2019 - Springer
Celiac disease (CD) is an immune-mediated gastrointestinal (GI) disorder driven by innate
and adaptive immune responses to gluten. Presentation of CD has changed over time, with …

[HTML][HTML] Aktualisierte S2k-leitlinie zöliakie der deutschen gesellschaft für gastroenterologie, verdauungs-und stoffwechselkrankheiten (DGVS)

J Felber, H Bläker, W Fischbach… - Zeitschrift für …, 2022 - thieme-connect.com
Bei der Zöliakie wird aufgrund des variablen Erscheinungsbildes auch vom „Chamäleon der
Gastroenterologie “gesprochen. Häufig wird nicht an diese Differenzialdiagnose gedacht …